CD4 and tuberculosis: INSPIRING (NCT02178592) is a phase 3b, non‐comparative, active control, randomised, open‐label study in HIV‐1‐infected adults’ naïve to antiretroviral therapy (CD4+ 350 cells/μL) with drug‐sensitive TB.